In this week’s podcast, we welcome Iddo Peleg, CEO and Co-Founder of Yonalink, who provides insights into the current and future state of the clinical trial industry. As we move headlong into 2025, a year that appears set to be characterized by global economic and political turmoil, Iddo discusses major trends in the industry, including challenges posed by the COVID-19 aftermath and the potential impacts of regulatory upheaval on clinical trials. 


The Pharma Letter Podcast — Episode 31 — How real-time data could transform clinical trials | Pharmaceutical | The Pharmaletter

The Pharma Letter Podcast — Episode 31 — How real-time data could transform clinical trials

column-header-date-desktop-only-1

column-header-logo-1

column-header-secondary-menu-desktop-only-1

row-header-1

row-header-and-main-menu-1

row-menu-container-1

code-sticky-header-1

row-header-background-1

banner-leaderboard

row-leaderboard

row-leaderboard-banner-bg-container

breadcrumb

row-breadcrumb

datasummary-page-title

row-title-row

row-row-category-date-container

row-category-date

column-main

column-sidebar

row-main-section

card-more-features-in-category

row-other-related

code-banner-spacer-3

banner-billboard-bottom

row-billboard-bottom

row-page

footer-first-column-2

footer-second-column-2

footer-third-column-2

row-footer-2

row-footer-container-2

copyright year-1

textblock-blaze-ref-1

row-copyright-and-blaze-1

backtotop-1

gtm-user-details-event-by-script

row-tracking-by-script

structured-data-component-header-auto

The Pharma Letter Podcast — Episode 31 — How real-time data could transform clinical trials

More on this story...

Today's issue

Company Spotlight

More Features in Pharmaceutical